A large number of clinical trials have shown stem cell therapy to be a promising therapeutic
approach for the treatment of cardiovascular diseases. Since the first transplantation into …

Endothelial progenitor cells (EPCs) are currently being studied as candidate cell sources for
revascularization strategies. Significant advances have been made in understanding the …

BACKGROUND Stem cell research in the endometrium and myometrium from animal
models and humans has led to the identification of endometrial/myometrial stem cells and …

Objective To assess if infusion of human bone marrow–derived stem cells (BMDSCs) could
promote follicle development in patients with impaired ovarian functions. Design …

Myocardial infarction is a leading cause of morbidity and mortality worldwide. Although
medical and surgical treatments can significantly improve patient outcomes, no treatment …

Over the past two decades cardiac cell therapy (CCT) has emerged as a promising new
strategy to cure heart diseases at high unmet need. Thousands of patients have entered …

Abstract Objectives The IMPACT-CABG trial is the first North American multicenter phase II
randomized study of intramyocardial delivery of autologous CD133+ stem cells in patients …

Tissue engineering is a branch of regenerative medicine, which comprises the combination
of biomaterials, cells and other bioactive molecules to regenerate tissues. Biomaterial …

Recent clinical studies have suggested that endothelial progenitor cells (EPC s)
transplantation provides a modest benefit for treatment of the ischaemic diseases such as …

Objective To investigate the effect of negative-pressure wound therapy (NPWT) on the
circulating number of endothelial progenitor cells (EPCs) in diabetic patients with mild to …